{"prompt": "['CIP HD01-16-30', 'HHELSINN', 'Version 1.0, 06/02/2017', 'Appendix 2', 'Study Flow-Chart for head & neck cancer subjects', 'RT &', '2 weeks', 'RT', 'Phase of the study', 'Screening', 'treatment', 'RT (expected 33-35 sessions)', 'treatment', 'end', 'without RT', 'start', 'Visit number', '1', '2', '3', '4', '5', '6', '7', '8', '9', '10', 'Week', '-', '0', '1', '2', '3', '4', '5', '6', '7', '9', 'Time (Days) 2 days', '-3 to 0', '1', '7', '14', '21', '28', '35', '42', '49', '63', 'Informed consent signature', 'X', 'Inclusion/Exclusion criteria', 'X', 'X', 'Patient randomization', 'X', 'Socio-demographic data', 'X', 'Medical and surgical history', 'X', 'collection', 'Physical examination', 'X', 'X', 'X', 'Concomitant medications and', 'X', 'X', 'X', 'therapies', 'ECOG performance status', 'X', 'Erythema assessment', 'X', 'X', 'X', 'Skindex-16 questionnaire', 'X', 'X', 'X', 'Spettrophotometry & TEWL', 'X', 'X', 'Study treatment dispensation to', 'X', 'patient', 'Study treatment return and', 'X', 'accountability', 'Patient diary dispensation', 'X', 'Patient diary collection', 'X', 'Patient Global Satisfaction score', 'X', 'Adverse events', 'X', 'X', 'X', 'CONFIDENTIAL', 'Page 44 of 53']['CIP HD01-16-30', 'HHELSINN', 'Version 1.0, 06/02/2017', 'Study Flow-Chart for breast cancer subjects', 'RT &', '2 weeks', 'RT', 'Phase of the study', 'Screening', 'treatment', 'RT (expected 30 sessions)', 'treatment', 'end', 'start', 'without RT', 'Visit number', '1', '2', '3', '4', '5', '6', '7', '8', '9', 'Week', '-', '0', '1', '2', '3', '4', '5', '6', '8', 'Time (Days) 2 days', '-3 to 0', '1', '7', '14', '21', '28', '35', '42', '56', 'Informed consent signature', 'X', 'Inclusion/Exclusion criteria', 'X', 'X', 'Patient randomization', 'X', 'Socio-demographic data', 'X', 'Medical and surgical history', 'X', 'collection', 'Physical examination', 'X', 'X', 'X', 'Concomitant medications and', 'X', 'X', 'X', 'therapies', 'ECOG performance status', 'X', 'Erythema assessment', 'X', 'X', 'X', 'Skindex-16 questionnaire', 'X', 'X', 'S Spettrophotometry & TEWL', 'X', 'X', 'Study treatment dispensation to', 'X', 'patient', 'Study treatment return and', 'X', 'accountability', 'Patient diary dispensation', 'X', 'X', 'Patient diary collection', 'X', 'X', 'Patient Global Satisfaction score', 'X', 'X', 'Adverse events', 'X', 'X', 'X', 'CONFIDENTIAL', 'Page 45 of 53']['CIP HD01-16-30', 'HHELSINN', 'Version 1.0, 06/02/2017', 'Appendix 3: SKINDEX-16 Questionnaire', 'QUESTIONARIO DERMATOLOGICO', 'Questo questionario riguarda il problema di pelle che le ha dato pi\u00f9 fastidio', 'negli ultimi 7 giorni.', 'kindex-16_Italian/italy_Mapi Research Institute', 'ID2251_Skindex16_AU2.0_ita-IT.doc', 'CONFIDENTIAL', 'Page 46 of 53']\n\n###\n\n", "completion": "END"}